• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

John Bissler - Articles and news items

Novartis logo
Novartis logo
Novartis logo

Novartis drug Afinitor® effective in patients with non-cancerous kidney tumors associated with TSC in Phase III trial

Industry news, News / 23 September 2011 / Novartis

A Phase III study of Afinitor® (everolimus) tablets* met its primary endpoint of best overall angiomyolipoma response rate…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionWATCH NOW
+ +